Related Experiment Video
Updated: May 31, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
The histamine H₄ receptor: targeting inflammatory disorders
Miriam Walter1, Tim Kottke, Holger Stark
1Johann Wolfgang Goethe University, Institute of Pharmaceutical Chemistry, Biocenter, ZAFES/LiFF/CMP/ICNF, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany.
The histamine H(4) receptor, found on immune cells, plays a key role in inflammation. Targeting this receptor offers a promising new approach for treating allergic and autoimmune diseases.
Area of Science:
- Immunology
- Pharmacology
- Biochemistry
Background:
- The histamine H(4) receptor is a recently discovered biogenic amine receptor.
- It is primarily expressed on immune cells, including mast cells, eosinophils, monocytes, dendritic cells, and T cells.
- The receptor plays a significant role in immune cell chemotaxis and modulating immune responses.
Purpose of the Study:
- To explore the physiological relevance of the histamine H(4) receptor in inflammatory and immunological processes.
- To investigate the potential of histamine H(4) receptor ligands as therapeutic agents for inflammatory and autoimmune diseases.
- To evaluate the limitations of histamine H(1) receptor antagonists in treating conditions like chronic pruritus, asthma, and allergic rhinitis.
Main Methods:
- Review of existing literature on histamine receptor research.
- Analysis of the expression patterns and functional roles of the histamine H(4) receptor.
- Examination of preclinical studies on selective H(4) receptor ligands and combined H(1)/H(4) receptor modulation.
Main Results:
- The histamine H(4) receptor is crucial for immune cell function and inflammatory processes.
- Histamine H(1) receptor antagonists show limitations in treating certain inflammatory conditions.
- Selective H(4) receptor ligands and dual H(1)/H(4) receptor modulation show promise in preclinical studies.
- First H(4) receptor antagonists have entered clinical trials for respiratory diseases.
Conclusions:
- The histamine H(4) receptor is a significant target for treating inflammatory and autoimmune disorders.
- Targeting the H(4) receptor, potentially in combination with H(1) receptor modulation, may offer improved therapeutic outcomes.
- Further research and clinical development of H(4) receptor antagonists are warranted.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Gastritis II: Pathophysiology
Acute Inflammation I: Inflammatory Response
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation
Allergic Drug Reactions
